Published in Law and Health Weekly, October 23rd, 2004
"The cftrtm1Unc-knockout (CF-KO) mouse is being evaluated as a model of increased drug clearance noted clinically" in CF patients," scientists in the United States explained.
"Clinical observations have suggested reduced responses to omeprazole in CF children, which may reflect alterations in bioavailability or...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.